Amrize has a credible North American growth story tied to data centers and infrastructure, but execution risk and cyclical pressure keep the stock at Hold. Q3 showed solid revenue and cash generation, yet earnings momentum remains uneven.
Amrize Ltd. (AMRZ) is a North American building materials platform with a credible medium-term growth case, but the stock carries execution and cyclicality risks that support a Hold recommendation for moderate-risk investors. The investment case rests on 8.6% Q2 2026 revenue growth, 2.2% Q3 growth, strong exposure to data centers and infrastructure, and a forward P/E of 13.4x. The counterweight is a 1/6 recent earnings beat rate, Q3 adjusted EPS that was flat year over year at $1.05, and Building Envelope adjusted EBITDA down 14.6% in Q3.
Amrize has tangible operating assets behind the story. Its network spans more than 1,000 sites and facilities, serves more than 23,000 customers, and employs about 19,000 people. Its Q3 2026 results showed $3.8B of revenue, $1.1B of adjusted EBITDA, and $558M of net income. The business is producing cash, with current free cash flow of $3.0B and a 13.6% FCF yield in the financial data.
The central judgment is that Amrize deserves a solid industrial valuation, not a premium-growth multiple. Building Materials is executing well, ASPIRE savings are progressing, and Texas acquisitions add local density. Yet weather, freight, diesel, raw material inflation, and rate-sensitive residential construction remain active constraints. The result is a good business with a reasonable price structure, rather than a clear mispricing.
Amrize is a North America-focused building solutions company operating through Building Materials and Building Envelope. Building Materials includes cement, aggregates, ready-mix concrete, asphalt, and related construction materials. Building Envelope includes roofing systems, insulation, shingles, sheathing, waterproofing, coatings, adhesives, tapes, and sealants.
The company became an independent public company on June 23, 2025, after the separation from Holcim. That creates a short standalone public-market history, but the operating platform is substantial. Amrize is led by CEO and Chairman Jan Philipp Jenisch, with Jaime Hill leading Building Materials and Samuel Poletti serving as Chief Financial Officer in the corporate information provided.
Amrize describes itself as the largest building solutions company fully focused on North America, the largest cement provider in the U.S. and Canada by sales and production volume, and the second-largest commercial roofing company in North America by sales. Those positions give the company exposure to both heavy, logistics-intensive materials and higher-value systems sold into the building envelope.
The platform is concentrated in the United States and Canada rather than spread across global markets. That focus supports local scale and domestic sourcing, while also making AMRZ more sensitive to North American construction cycles than diversified competitors such as CRH, Heidelberg Materials, and Cemex.
Building Materials remains the economic engine. Q3 2026 revenue was $2.8B, up 1.8% year over year, while adjusted EBITDA reached $938M, up 2.7%. Cement pricing rose 1.8% and aggregates pricing rose 6.9%, offsetting cement volume down 4.2% and aggregates volume down 0.2% during a weather-affected quarter.
The Q2 2026 operating picture was stronger on volume. Cement volume increased 5.0%, aggregates volume increased 6.5%, and Building Materials revenue rose 8.2% to $2.4B. Adjusted EBITDA increased 5.2% to $793M. That contrast between Q2 and Q3 matters: pricing and acquisitions protected results in Q3, while Q2 had broader volume support.
Building Envelope delivered Q3 revenue of $929M, up 3.6%, but adjusted EBITDA fell 14.6% to $182M. Commercial roofing benefited from data centers and industrial projects, while shingle volumes faced a lack of significant storms and sluggish existing-home sales. The segment is gaining sales traction, but earnings conversion remains the weaker part of the portfolio.
Management's Q3 guidance set 2026 revenue at $12.2B to $12.4B and adjusted EBITDA at $2.95B to $3.05B. The lower earnings framework compared with the earlier Q2 guidance reflects the real cost of oil-driven freight, diesel, and raw material inflation.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
Cement is the flagship product because it anchors the company's upstream network and connects directly with ready-mix, aggregates, infrastructure, and large commercial projects. Amrize completed a 660,000-ton capacity expansion at its flagship Missouri cement plant, described as the largest market-leading plant in North America.
Additional cement capacity is being added through a 300,000-ton expansion at Saint-Constant in Quebec, 100,000 tons at Midlothian in Texas, and 50,000 tons at Exshaw in Alberta. These projects place capacity near markets tied to energy projects, data centers, population growth, and infrastructure work.
The flagship downstream offering is the Elevate roofing system. Management cited Elevate installations at a major West Texas data center in Q2 and highlighted Elevate UltraPly TPO at a Washington freezer facility and Elevate MAX PVC 7 at Celina High School in Ohio in the Q3 presentation.
The product advantage is less about a single breakthrough item and more about project coverage. Amrize can supply cement and aggregates for the foundation while also selling roofing, insulation, waterproofing, and wall systems higher in the structure. That gives the company more opportunities to participate in a customer's total project spend.
Amrize's strongest competitive advantage is a combination of footprint, reserves, product breadth, and distribution. Management said its network can serve more than 90% of the more than 300 new data centers planned across North America. The company also reported more than 120 data center projects completed or in progress in the Q2 materials.
The company is investing in supplementary cementitious materials and cement additives, which delivered double-digit volume growth in Q2. It is also developing six aggregate quarry projects that add more than 150 million tons of reserves, according to the Q3 presentation. Reserves and permitted local capacity are strategic assets in a business where transportation costs quickly erode margins.
Operational innovation is also visible in ASPIRE. Amrize delivered $73M of ASPIRE savings year to date in 2026 and remains on track for about $80M during the year and $250M through 2028. The program covers raw materials, services, logistics, and equipment, with approximately 1,000 suppliers onboarded in 2026.
That statement captures the moat more accurately than the usual innovation vocabulary. Amrize's advantage is an engineered network that is difficult to replicate quickly, not a software feature that can be copied over a weekend.
The supply chain is both an advantage and a risk. Cement, aggregates, and ready-mix are heavy products with limited economic shipping distances. Amrize's more than 1,000 sites, local-to-local model, quarry reserves, and terminal expansions support regional service and reduce dependence on long-distance imports.
The company is expanding terminals in Memphis, Kansas City, Cincinnati, Columbus, and Lubbock. It is also building the Malarkey shingles plant in Indiana to extend Building Envelope coverage into the Midwest and Eastern markets.
Supply chain inflation is the main operational pressure. Q2 results absorbed higher freight, diesel, and raw material costs, while Q3 management continued to identify oil-price-driven inflation as a headwind. Fuel surcharges and price increases are offsetting part of the pressure, but the timing gap between cost inflation and price realization has compressed margins.
Capital deployment is substantial. Amrize invested $262M of CapEx in Q3 and guides to about $900M for 2026. The company also acquired PB Materials and Rapid Redi-Mix in Texas. Those purchases contributed $77M of Q3 revenue and connect cement, aggregates, and ready-mix operations in a high-growth regional market.
Amrize estimates an annual addressable market of more than $140B for Building Materials and more than $60B for Building Envelope. It also frames the broader U.S. and Canadian construction market at more than $2T of annual spending across infrastructure, commercial, and residential construction.
The most attractive current pockets are data centers, energy infrastructure, advanced manufacturing, and public infrastructure. In Q2, management cited projects in West Texas, Illinois, Arizona, Louisiana, Montreal, and New York. In Q3, weather reduced construction volumes in the Northeast, South, and Central regions, but state and federally funded multiyear projects helped offset the weakness.
Commercial construction accounts for half of Amrize's business, according to management. This mix gives the company direct exposure to large projects with long construction timelines. It also leaves AMRZ exposed to elevated interest rates, project delays, and changes in corporate capital spending.
Residential construction is the less supportive market at present. Q3 shingle volumes were hurt by the lack of significant storms and sluggish existing-home sales, while higher rates and affordability constraints continue to weigh on new housing activity. The residential weakness is partly cushioned by reroofing, commercial roofing, infrastructure, and industrial demand.
Like what you're reading?
Get full access to AI-powered research reports, market analysis, and portfolio tools.
Amrize serves infrastructure, commercial, and residential construction markets across the United States and Canada. Its customer base exceeds 23,000, giving the company broad project exposure rather than dependence on one national buyer.
The highest-value customer opportunities are large contractors, infrastructure programs, commercial developers, industrial project owners, and roofing distribution channels. The Q2 project examples show Amrize supplying materials to data centers, semiconductor manufacturing, LNG facilities, an airport modernization, and the Hudson River Tunnel.
Customer purchasing is increasingly specification-driven. Large projects require reliable delivery, performance standards, and the ability to coordinate several material categories. Amrize's cement, aggregates, ready-mix, asphalt, roofing, and wall-system portfolio gives it more cross-selling opportunities than a single-product supplier.
The customer mix also explains the uneven quarterly results. Commercial and infrastructure customers supported Q2 volume growth, while residential roofing benefited from market-share gains in Q2 but faced storm and housing pressure in Q3. The portfolio is broad, but it is not immune to construction timing.
Competition varies by product and geography. Amrize identifies Cemex, Buzzi-Unicem, Heidelberg Materials, and CRH among its principal building materials competitors. In Building Envelope, relevant competitors include Carlisle, CertainTeed, GAF, Johns Manville, Owens Corning, and RPM.
U.S. aggregates competition also includes Vulcan Materials, Martin Marietta, Eagle Materials, and Granite Construction in overlapping markets. These companies compete through reserves, permits, plant locations, logistics, customer relationships, and pricing discipline. National scale helps, but local positioning often decides the contract.
AMRZ's distinguishing feature is its North America-only focus combined with a broad product stack. CRH, Heidelberg Materials, and Cemex have greater geographic diversification, while Amrize offers a more concentrated exposure to U.S. and Canadian infrastructure, construction, and data center investment.
The competitive advantage is strongest where Amrize can connect assets. PB Materials and Rapid Redi-Mix strengthen the Texas network, while the Midlothian expansion adds cement capacity near Dallas-Fort Worth. This is a practical form of vertical integration: the value comes from fewer handoffs, shorter logistics paths, and more products sold into the same project.
Higher interest rates remain a direct pressure on residential and commercial construction. The Q3 presentation tied residential weakness to higher rates, affordability challenges, lack of storms, and sluggish existing-home sales. Those pressures limit the speed of recovery in the most rate-sensitive parts of the portfolio.
Infrastructure is the stronger macro pillar. Amrize cited remaining Infrastructure Investment and Jobs Act funding and a successor bill as support for multiyear demand. Government-funded roads, tunnels, airports, energy networks, and water projects also create longer project timelines than speculative private construction.
Onshoring and domestic procurement support Amrize's footprint. Management said the United States and Canada are prioritizing domestic materials and highlighted Made in America and Product of Canada offerings. The local-to-local strategy reduces reliance on imports and places production near customers, although it does not remove exposure to fuel, freight, or labor costs.
Oil-price-driven inflation is the clearest near-term macro threat. Amrize expects approximately $140M to $170M of higher costs in its 2026 guidance bridge, primarily from freight, diesel, and raw materials. Management expects price-over-cost performance to turn positive in Q4, but the 2026 earnings framework still reflects the inflation shock.
Amrize’s balance sheet earns an A- thanks to $3.0B of current free cash flow and a 13.6% FCF yield, giving it room to fund expansion while navigating a cyclical market.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Q3 revenue reached $3.8B and adjusted EBITDA was $1.1B, but flat adjusted EPS of $1.05 and a 14.6% EBITDA decline in Building Envelope show earnings quality is uneven.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Management’s 2026 outlook calls for $12.2B to $12.4B of revenue and $2.95B to $3.05B of adjusted EBITDA, implying a more cautious earnings path than earlier guidance.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →At 13.4x forward P/E, Amrize trades at a solid industrial multiple that looks fair rather than cheap given its cyclical exposure and mixed earnings trend.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →The report’s valuation framework centers on a $46 fair value, with upside and downside bands stretching from $37 for Buy to $54 for Sell.
Unlock the full analysis
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
Get Full Access →Amrize combines a strong North American footprint with exposure to some of the most capital-intensive construction projects in the market. Q2 volume growth, Q3 pricing gains, $73M of ASPIRE savings year to date, and $77M of Q3 revenue from recent acquisitions show a business still building operating momentum.
The investment case is not without friction. Q3 adjusted EPS was flat, Building Envelope profitability declined, the recent earnings beat rate was 1/6, and oil-driven costs remain a direct threat to margins. Amrize has the assets and liquidity to manage those pressures, but the valuation already recognizes much of the underlying quality.
For a medium-term, moderate-risk portfolio, AMRZ fits best as a Hold near $46 rather than an aggressive purchase at elevated levels. The most compelling risk-reward begins closer to $37, where the company's cash generation, infrastructure exposure, and local market density would provide a wider margin of safety.
Get AI-powered research reports, daily market intelligence, and a personal analyst in your pocket.
Get Full Access →Not ready to subscribe? ·
Cancel anytime
Amrize AG (AMRZ) slips after a modest earnings miss, but the deeper story is softer volume, thinner margins, and weakening cash conversion. Pricing helped offset some pressure, yet adjusted EBITDA barely grew and free cash flow remained negative, tempering the case for a quick rebound.
Amrize AG (AMRZ) slips 0.5% after reporting earnings misses, with investors reacting to weaker-than-expected results and pressure on the stock.
Five Amrize officers bought $839,000 of AMRZ shares just as analysts turned more negative on margins. The damage is real, but pricing actions, Building Materials growth and a stock near its 52-week low make the selloff look excessive.